• / Free eNewsletters & Magazine
  • / My Account
Home>Lilly's Type 2 Diabetes Drug Trulicity Gets FDA OK -- 2nd Update

Lilly's Type 2 Diabetes Drug Trulicity Gets FDA OK -- 2nd Update

3party Content

Fri, 19 Sep 2014

By Josh Beckerman Eli Lilly & Co.'s (LLY) Type 2 diabetes drug Trulicity has been approved by the U.S. Food and Drug Administration, the agency said Thursday. The drug is a subcutaneous injection that helps improve blood-sugar levels. Lilly plans to launch Trulicity 0.75 mg and 1.5 mg single-dose
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.